Type to search

EQRx and Exscientia Enter Strategic Drug Creation, Development, and Commercialization Collaboration to Accelerate the Advancement of New World-Class Medicines | Pharmtech Focus
Exscientia Announces Second Molecule Created Using AI from Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trial | Pharmtech Focus
Exscientia Announces First AI-Designed Immuno-Oncology Drug to Enter Clinical Trials | Pharmtech Focus